LTC Properties Inc: Form 10-Q for the period ended Sep 30, 2021
Filed with the SEC on Oct 28, 2021 and accepted by EDGAR at Oct 28, 2021, 16:24 ET.
Management's discussion and analysis
As filed, 75,108 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Cautionary Statement Regarding Forward-Looking Statements
This quarterly report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, adopted pursuant to the Private Securities Litigation Reform Act of 1995. Statements that are not purely historical may be forward-looking. You can identify some of the forward-looking statements by their use of forward-looking words, such as “believes,” “expects,” “may,” “will,” “could,” “would,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates” or “anticipates,” or the negative of those words or similar words. Forward-looking statements involve inherent risks and uncertainties regarding events, conditions and financial trends that may affect our future plans of operation, business strategy, results of operations and financial position. A number of important factors could cause actual results to differ materially from those included within or contemplated by such forward-looking statements, including, but not limited to, our dependence on our operators for revenue and cash flow; the duration and extent of the effects of the COVID-19 pandemic; government regulation of the health care industry; federal and state health care cost containment measures including reductions in reimbursement from third-party payors such as Medicare and Medicaid; required regulatory approvals for operation of health care facilities; a failure to comply with federal, state, or local regulations for the operation of health care facilities; the adequacy of insurance coverage maintained by our operators; our reliance on a few major operators; our ability to renew leases or enter into favorable terms of renewals or new leases; operator financial or legal difficulties; the sufficiency of collateral securing mortgage loans; an impairment of our real estate investments; the relative illiquidity of our real estate investments; our ability to develop and complete construction projects; our ability to invest cash proceeds for health care properties; a failure to qualify as a REIT; our ability to grow if access to capital is limited; and a failure to maintain or increase our dividend. For a discussion of these and other factors that could cause actual results to differ from those contemplated in the forward-looking statements, please see the discussion under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and in our publicly available filings with the Securities and Exchange Commission. We do not undertake any responsibility to update or revise any of these factors or to announce publicly any revisions to forward-looking statements, whether as a result of new information, future events or otherwise.
Executive Overview
Business and Investment Strategy
We are a real estate investment trust (“REIT”) that invests in seniors housing and health care properties through sale-leaseback transactions, mortgage financing, joint ventures, construction financing and structured finance solutions including mezzanine lending. Our primary objectives are to create, sustain and enhance stockholder equity value and provide current income for distribution to stockholders through real estate investments in seniors housing and health care properties managed by experienced operators.
The following graph summarizes our gross investments as of September 30, 2021:
Our primary seniors housing and health care property classifications include skilled nursing centers (“SNF”), assisted living communities (“ALF”), independent living communities (“ILF”), memory care communities (“MC”) and combinations thereof. We conduct and manage our business as one operating segment, rather than multiple operating segments, for internal reporting and internal decision-making purposes. For purposes of this quarterly report and other presentations, we generally include ALF, ILF, MC, and combinations thereof in the ALF classification. As of September 30, 2021, seniors housing and long-term health care properties comprised approximately 99.2% of our real estate investment portfolio. We have been operating since August 1992.
Substantially all of our revenues and sources of cash flows from operations are derived from operating lease rentals, interest earned on outstanding loans receivable and income from investments in unconsolidated joint ventures. Income from our investments in owned properties and mortgage loans represent our primary source of liquidity to fund distributions and are dependent upon the performance of the operators on their lease and loan obligations and the rates earned thereon. To the extent that the operators experience operating difficulties and are unable to generate sufficient cash to make payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by property type and operator. Our monitoring process includes periodic review of financial statements for each facility, periodic review of operator credit, scheduled property inspections and review of covenant compliance.
In addition to our monitoring and research efforts, we also structure our investments to help mitigate payment risk. Some operating leases and loans are credit enhanced by guaranties and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross- defaulted and cross-collateralized with other loans, operating leases or agreements between us and the operator and its affiliates.
Depending upon the availability and cost of external capital, we anticipate making additional investments in health care related properties. New investments are generally funded from cash on hand, proceeds from periodic asset sales, temporary borrowings under our unsecured revolving line of credit and internally generated cash flows. Our investments generate internal cash from rent and interest receipts and principal payments on mortgage loans receivable. Permanent financing for future investments, which replaces funds drawn under our unsecured revolving line of credit, is expected to be provided through a combination of public and private offerings of debt and equity securities and secured and unsecured debt financing. The timing, source and amount of cash flows provided by financing activities and used in investing activities are sensitive to the capital markets’ environment, especially to changes in interest rates. Changes in the capital markets’ environment may impact the availability of cost-effective capital.
We believe our business model has enabled and will continue to enable us to maintain the integrity of our property investments, including in response to financial difficulties that may be experienced by operators. Traditionally, we have taken a conservative approach to managing our business, choosing to maintain liquidity and exercise patience until favorable investment opportunities arise.
COVID-19
On March 11, 2020, the World Health Organization declared the outbreak of coronavirus (“COVID-19”) as a pandemic, and on March 13, 2020, the United States declared a national emergency with regard to COVID-19. The COVID-19 pandemic has had repercussions across regional and global economies and financial markets. The outbreak of COVID-19 in many countries, including the United States, has significantly and adversely impacted public health and economic activity, and has contributed to significant volatility, dislocations and liquidity disruptions in financial markets.
The operations and occupancy levels at our properties have been adversely affected by COVID-19 and could be further adversely affected by COVID-19 or another pandemic especially if there are infections on a large scale at our properties. The impact of COVID-19 has included, and another pandemic could include, early resident move-outs, our operators delaying accepting new residents due to quarantines, potential occupants postponing moves to our operators’ facilities, and/or hospitals cancelling or significantly reducing elective surgeries thereby there were fewer people in need of skilled nursing care. Additionally, as our operators have responded to the pandemic, operating costs have begun to rise. A decrease in occupancy, ability to collect rents from residents and/or increase in operating costs could have a material adverse effect on the ability of our operators to meet their financial and other contractual obligations to us, including the payment of rent. In recognition of the pandemic impact affecting our operators, we have agreed to rent abatements totaling $3.8 million and rent deferrals for certain operators totaling $6.1 million between April 2020 and September 2021, of which $1.7 million subsequently has been repaid. The $8.2 million in rent abatements and deferrals, net of repayments, represented approximately 2.9% of our April 2020 through September 2021 contractual rent and interest. The remaining balance of deferred rent is due to us over the next 36 months or upon receipt of government funds from the U.S. Coronavirus Aid, Relief, and Economic Security (the “CARES Act”).
During the nine months ended September 30, 2021, we proactively provided additional financial support to the majority of our operators by reducing 2021 rent and interest escalations by 50%. The rent and interest escalation reduction were given in the form of a rent and interest credit in recognition of operators’ increased costs due to COVID-19. During nine months ended September 30, 2021, we recognized a GAAP revenue decrease of $0.5 million and a cash revenue decrease of $1.3 million related to the 50% escalation reduction. We expect the escalation reductions to have a de minimis effect on GAAP revenue during the fourth quarter of 2021.
Real Estate Portfolio Overview
The following tables summarize our real estate investment portfolio by owned properties and mortgage loans and by property type, as of September 30, 2021 (dollar amounts in thousands):
| Owned Properties | | Gross Investments | | Percentage of Investments | Nine Months Ended September 30, 2021 Rental Income (1) | | Interest Income | | Percentage of Revenues | | Number of Properties (2) | | Number of SNF Beds (3) | | ALF Units (3) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assisted Living | | $843,015 | | 50.5% | $40,236 | | $— | | 38.5% | | 102 | | — | | 5,798 |
| Skilled Nursing | | 552,723 | | 33.1% | 39,809 | | — | | 38.1% | | 50 | | 6,154 | | 212 |
| Other (4) | | 11,360 | | 0.7% | 725 | | — | | 0.7% | | 1 | | 118 | | — |
| Total Owned Properties | | 1,407,098 | | 84.3% | 80,770 | | — | | 77.3% | | 153 | | 6,272 | | 6,010 |
| | | | | | | | | | | | | | | | |
| Mortgage Loans | | | | | | | | | | | | | | | |
| Skilled Nursing | | 259,657 | | 15.6% | — | | 23,779 | | 22.7% | | 22 | | 2,727 | | — |
| Other (4) | | 1,780 | | 0.1% | — | | — | | —% | | — | | — | | — |
| Total Mortgage Loans | | 261,437 | | 15.7% | — | | 23,779 | | 22.7% | | 22 | | 2,727 | | — |
| | | | | | | | | | | | | | | | |
| Total Portfolio | | $1,668,535 | | 100.0% | $80,770 | | $23,779 | | 100.0% | | 175 | | 8,999 | | 6,010 |
| Summary of Properties by Type | | Gross Investments | | Percentage of Investments | Nine Months Ended September 30, 2021 Rental Income (1) | | Interest Income | | Percentage of Revenues | | Number of Properties (2) | | Number of SNF Beds (3) | | ALF Units (3) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assisted Living | | $843,015 | | 50.5% | $40,236 | | $— | | 38.5% | | 102 | | — | | 5,798 |
| Skilled Nursing | | 812,380 | | 48.7% | 39,809 | | 23,779 | | 60.8% | | 72 | | 8,881 | | 212 |
| Other (4) | | 13,140 | | 0.8% | 725 | | — | | 0.7% | | 1 | | 118 | | — |
| Total Portfolio | | $1,668,535 | | 100.0% | $80,770 | | $23,779 | | 100.0% | | 175 | | 8,999 | | 6,010 |
(1) Excludes variable rental income from lessee reimbursement and rental income from sold properties.
(2) We have investments in owned properties and mortgage loans in 26 states leased or mortgaged to 31 different operators.
(3) See Item 1. Financial Statements – Note 2. Real Estate Investments for discussion of bed/unit count.
(4) Includes three parcels of land held-for-use, one behavioral health care hospital and one parcel of land securing a first mortgage held for future development of a post-acute skilled nursing center.
As of September 30, 2021, we had $1.3 billion in net carrying value of real estate investments, consisting of $1.0 billion or 80.1% invested in owned and leased properties and $0.3 billion or 19.9% invested in mortgage loans secured by first mortgages. Our investment in mortgage loans mature between 2022 and 2045 and contain interest rates between 7.5% and 10.1%.
For the nine months ended September 30, 2021, rental income represented 78.6% of total gross revenues, interest income from mortgage loans represented 20.5% of total gross revenues and interest and other income represented 0.9% of total gross revenues. In most instances, our lease structure contains fixed annual rental escalations and/or annual rental escalations that are contingent upon changes in the Consumer Price Index. Certain leases have annual rental escalations that are contingent upon changes in the gross operating revenues of the property. This revenue is not recognized until the appropriate contingencies have been resolved.
For the nine months ended September 30, 2021, we recorded $0.6 million in straight-line rental income and amortization of lease incentive cost of $0.4 million. During the nine months ended September 30, 2021, we received $91.6 million of cash rental income, which includes $10.7 million of operator reimbursements for our real estate taxes. At September 30, 2021, the straight-line rent receivable balance, net of write-offs for uncollectible amounts, on the balance sheet was $24.3 million.
Update on Certain Operators
Senior Care Centers, LLC
Senior Care Centers, LLC and affiliates and subsidiaries (“Senior Care”) filed for Chapter 11 bankruptcy in December 2018. During 2019, while in bankruptcy, Senior Care assumed LTC’s master lease and, in March 2020, Senior Care emerged from bankruptcy. Concurrent with their emergence from bankruptcy, in accordance with the order confirming Senior Care’s plan of reorganization, Abri Health Services, LLC (“Abri Health”) was formed as the parent company of reorganized Senior Care and became co-tenant and co-obligor with reorganized Senior Care under our master lease. In March 2021, Senior Care and Abri Health (collectively, “Lessee”) failed to pay rent and additional obligations owed under the master lease. Accordingly, we sent a notice of default and applied proceeds from letters of credit to certain obligations owed under the master lease. Furthermore, we sent the Lessee a notice of termination of the master lease to be effective April 17, 2021. On April 16, 2021, the Lessee filed for Chapter 11 bankruptcy. In August 2021, the United States Bankruptcy Court approved a settlement agreement between Lessee and LTC. The settlement provides for, among other things, a one-time payment of $3.3 million from LTC to the affiliates of Lessee in exchange for cooperation and assistance in facilitating an orderly transition of the 11 skilled nursing centers from the Lessee and its affiliates to affiliates of HMG Healthcare, LLC which occurred on October 1, 2021.
Brookdale Senior Living Communities, Inc
Brookdale Senior Living Communities, Inc’s (“Brookdale”) master lease was scheduled for expiration on December 31, 2021. During the first quarter of 2021, we extended their term by one year through an amended master lease, with a new maturity date of December 31, 2022. Also, the renewal options under the amended master lease will remain the same which provides three renewal options consisting of a three-year renewal option, a five-year renewal option and a 10-year renewal option. The notice period for the first renewal option is January 1, 2022 to April 30, 2022. During 2020, we extended a $4.0 million capital commitment to Brookdale, which is available through December 31, 2021 at a 7% yield. As of September 30, 2021, we have funded $3.3 million under this agreement and our remaining commitment is $0.7 million. Brookdale is current on rent payments through October 2021.
Senior Lifestyle Corporation
During 2020, an affiliate of Senior Lifestyle (“Senior Lifestyle”) paid us $13.8 million of their $18.4 million contractual rent and we applied their letter of credit and deposits totaling $3.7 million to past due rent of $3.6 million and to their outstanding notes receivable of $0.1 million. Accordingly, we wrote-off a total $17.7 million of straight-line rent receivable and lease incentives related to this master lease and transitioned rental revenue recognition to cash basis effective July 2020. During 2020, we recognized $17.4 million of rental revenue from Senior Lifestyle. To date in 2021, Senior Lifestyle has not paid rent or its other obligations under the master lease. During 2021, we transition 18 assisted living communities previously leased to Senior Lifestyle to five operators. These communities are located in Illinois, Ohio, Wisconsin, Colorado, Pennsylvania and Nebraska. Also, during 2021, we sold three Wisconsin communities and a closed community in Nebraska previously leased to Senior Lifestyle for a combined total of $35.9 million. We received total proceeds of $34.8 million and recorded a net gain on sale of $5.4 million. We expect to transition the remaining New Jersey community to an existing operator during the fourth quarter of 2021.
Genesis Healthcare, Inc
Genesis reported doubt regarding its ability to continue as a going concern on its Quarterly Report on Form 10-Q filed in August 2020. As a result, we wrote-off $4.3 million of straight-line rent receivable related to this master lease during the third quarter of 2020 and transitioned rental revenue recognition to cash basis effective September 2020. During the first quarter of 2021, Genesis delisted its Class A common stock from the New York Stock Exchange. Genesis is current on rent payments through October 2021.
Other Operators
During the third quarter of 2020, an operator failed to pay its full contractual rent. Accordingly, we wrote-off $1.2 million of straight-line rent receivable related to this master lease. During 2020, we consolidated our two master leases with this operator into one combined master lease and agreed to abate $0.7 million of rent and allow the operator to defer rent as needed through March 31, 2021. During 2021, the combined master lease was amended to extend the rent deferral period through December 31, 2021. The operator deferred rent of $1.2 million for the third quarter of 2021 and $0.4 million for October 2021. The deferred balance due from this operator is $4.1 million as of October 2021. The operator can defer rent up to $0.4 million for each of November and December 2021.
2021 Rent deferrals, net of repayments, and abatements (in thousands):
| | | Three Months Ended March 31, 2021 | | June 30, 2021 | | September 30, 2021 | | October 2021 | |
|---|---|---|---|---|---|---|---|---|---|
| Rent deferrals, net of repayments | | $1,122 | | $1,121 | | $1,300 | | $438 | |
| Rent abatements | | 600 | | 1,069 | | 970 | | 240 | |
| 50% reduction of 2021 rent & interest escalations | | 1,204 | | 133 | | — | | — | |
| | | $2,926 | | $2,323 | | $2,270 | | $678 | |
Subsequent to September 30, 2021, we have agreed to provide rent deferrals up to $0.4 million and abatements up to $0.2 million for each of November and December 2021.
2021 Activities Overview
The following tables summarize our transactions during the nine months ended September 30, 2021 (dollar amounts in thousands):
Investment in Development and Improvement projects
| | | Developments | | Improvements |
|---|---|---|---|---|
| Assisted Living Communities | | $— | | $4,560 |
| Skilled Nursing Centers | | — | | 279 |
| Total | | $— | | $4,839 |
Properties Sold
| State | | Type of Properties | | Number of Properties | | Number of Beds/Units | | Sales Price | | Carrying Value | | Net Gain (loss) (1) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n/a | | n/a | | — | | — | | $— | | $— | | $292 | (2) (3) |
| Florida | | ALF | | 1 | | — | | 2,000 | | 2,626 | | (858) | |
| Nebraska | | ALF | | 1 | | 40 | | 900 | | 1,079 | | (198) | |
| Washington | | SNF | | 1 | | 123 | | 7,700 | | 4,528 | | 2,562 | |
| Wisconsin | | ALF | | 3 | | 263 | | 35,000 | | 28,295 | | 5,594 | |
| | | | | 6 | | 426 | | $45,600 | | $36,528 | | $7,392 | |
(1) Calculation of net gain (loss) includes cost of sales.
(2) We recognized additional gain due to the reassessment adjustment of the holdbacks related to properties sold during 2019 and 2020, under the expected value model per ASC *Topic 606, Contracts with Customers (“*ASC 606”).
(3) One of the transactions includes a holdback of $838 which is held in an interest-bearing account with an escrow holder on behalf of the buyer for potential specific losses. During 2020, we received $150 of the holdback. The remaining holdback expires in March 2022. Using the expected value model per ASC 606, we estimated and recorded the holdback value of $471 at closing.
Investment in Mortgage Loans
| | | | |
|---|---|---|---|
| Originations and funding under mortgage loans receivable | | $2,223 | (1) |
| Scheduled principal payments received | | (625) | |
| Mortgage loan premium amortization | | (4) | |
| Provision for loan loss reserve | | (16) | |
| Net increase in mortgage loans receivable | | $1,578 | |
(1) Subsequent to September 30, 2021, we funded a $27,047 mortgage loan secured by a 189-bed SNF in Louisiana with a regional operator new to us. The mortgage loan has a three-year term, with one 12-month extension option and a yield of 7.5%. Additionally, we funded a $12,530 mortgage loan secured by a 68-unit ALF and MC community in Florida operated by a regional operator new to us. The mortgage loan term is approximately 4 years at a 7.75% yield and includes an additional $4,177 loan commitment for the construction of a memory care addition to the property to be funded at a later date subject to satisfaction of various conditions.
Investment in Unconsolidated Joint Ventures
| State | | Type of Properties | | Type of Investment | | Total Preferred Return | | Contractual Cash Portion | | Number of Beds/ Units | | Carrying Value | | 2021 Capital Contribution | | Income Recognized | | Cash Interest Received | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Washington (1) | | UDP | | Preferred Equity | (1) | 12% | | 7% | | — | | $6,340 | | $— | | $337 | | $300 | |
| Washington (2) | | UDP | | Preferred Equity | (2) | 12% | | 8% | | — | | 13,000 | | 8,000 | | 704 | | 616 | |
| | | | | | | | | | | — | | $19,340 | | $8,000 | | $1,041 | | $916 | |
(1) Invested $6,340 of preferred equity in an entity that will develop and own a 95-unit ALF/MC in Washington and withheld $1,425 as a reserve. Our investment represents 15.5% of the estimated total investment. The preferred equity investment earns an initial cash rate of 7% increasing to 9% in year four until the internal rate of return (“IRR”) is 8%. After achieving an 8% IRR, the cash rate drops to 8% until achieving an IRR ranging between 12% to 14%.
(2) Invested $13,000 of preferred equity in an entity that will develop and own a 267-unit ILF/ALF in Washington and withheld $3,777 as a reserve. Our investment represents 11.6% of the estimated total investment. The preferred equity investment earns an initial cash rate of 8% until achieving an IRR ranging between 12% and 14%.
Notes Receivable
| | | | | |
|---|---|---|---|---|
| Advances under notes receivable | $6,453 | (1) (2) | ||
| Interest reserve withheld | | 353 | | |
| Principal payments received under notes receivable | | (2,553) | | |
| Notes receivable reserve | | 43 | | |
| Net increase in notes receivable | | $4,296 | | |
(1) Funding under working capital notes and mezzanine loans with interest ranging between 5% and 8% and maturities between 2022 and 2030.
(2) Subsequent to September 30, 2021, we provided HMG a $25,000 secured working capital loan maturing in September 2022 to facilitate the transition of the 11 properties from Senior Care and Abri Health.
Health Care Regulatory Climate
The Centers for Medicare & Medicaid Services (“CMS”) annually updates Medicare skilled nursing facility (“SNF”) prospective payment system rates and other policies. On July 30, 2019, CMS issued its final fiscal year 2020 Medicare skilled nursing facility update. Under the final rule, CMS projected aggregate payments to SNFs would increase by $851 million, or 2.4%, for fiscal year 2020 compared with fiscal year 2019. The final rule also addressed implementation of the new Patient-Driven Payment Model case mix classification system that became effective on October 1, 2019, changes to the group therapy definition in the skilled nursing facility setting, and various SNF Value-Based Purchasing and quality reporting program policies. On April 10, 2020, CMS issued a proposed rule to update SNF rates and policies for fiscal year 2021, which started October 1, 2020, and issued the final rule on July 31, 2020. CMS estimated that payments to SNFs would increase by $750 million, or 2.2%, for fiscal year 2021 compared to fiscal year 2020. CMS also adopted revised geographic delineations to identify a provider’s status as an urban or rural facility and to calculate the wage index, applying a 5% cap on any decreases in a provider’s wage index from fiscal year 2020 to fiscal year 2021. Finally, CMS also finalized updates to the SNF value-based purchasing program to reflect previously finalized policies, updated the 30-day phase one review and correction deadline for the baseline period quality measure quarterly report, and announced performance periods and performance standards for the fiscal year 2023 program year. On April 8, 2021, CMS issued a proposed rule to update SNF rates and policies for fiscal year 2022, which started October 1, 2021, and issued the final rule on July 29, 2021. CMS estimated that the aggregate impact of the payment policies in the final rule would result in an increase of approximately $410 million in Medicare Part A payments to SNFs in fiscal year 2022. The final rule also includes several policies that update the SNF Quality Reporting Program and the SNF Value-Based Program for fiscal year 2022.
Since the announcement of the COVID-19 pandemic and beginning as of March 13, 2020, CMS has issued numerous temporary regulatory waivers and new rules to assist health care providers, including SNFs, respond to the COVID-19 pandemic. These include waiving the SNF 3-day qualifying inpatient hospital stay requirement, flexibility in calculating a new Medicare benefit period, waiving timing for completing functional assessments, waiving requirements for health care professional licensure, survey and certification, provider enrollment, and reimbursement for services performed by telehealth, among many others. CMS also announced a temporary expansion of its Accelerated and Advance Payment Program to allow SNFs and certain other Medicare providers to request accelerated or advance payments in an amount up to 100% of the Medicare Part A payments they received from October–December 2019; this expansion was suspended April 26, 2020 in light of other CARES Act funding relief. The Continuing Appropriations Acts, 2021 and Other Extensions Act, enacted on October 1, 2020, amended the repayment terms for all providers and suppliers that requested and received accelerated and advance payments during the COVID-19 public health emergency. Specifically, Congress gave providers and suppliers that received Medicare accelerated and advance payment(s) one year from when the first loan payment was made to begin making repayments. In addition, CMS has also enhanced requirements for nursing facilities to report COVID-19 infections to local, state and federal authorities. On October 15, 2021, HHS Secretary Becerra announced that he had renewed, effective October 18, 2021, the declared public health emergency for an additional 90-day period.
On March 26, 2020, President Trump signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), sweeping legislation intended to bolster the nation’s response to the COVID-19 pandemic. In addition to offering economic relief to individuals and impacted businesses, the law expands coverage of COVID-19 testing and preventative services, addresses health care workforce needs, eases restrictions on telehealth services during the crisis, and increases Medicare regulatory flexibility, among many other provisions. Notably, the CARES Act temporarily suspended the 2% across-the-board “sequestration” reduction during the period May 1, 2020 through December 31, 2020, and extends the current Medicare sequester requirement through fiscal year 2030. In addition, the law provides $100 billion in grants to eligible health care providers for health care related expenses or lost revenues that are attributable to COVID-19. On April 10, 2020, CMS announced the distribution of $30 billion in funds to Medicare providers based upon their 2019 Medicare fee for service revenues. Eligible providers were required to agree to certain terms and conditions in receiving these grants. In addition, the Department of Health and Human Services (“HHS”) authorized $20 billion of additional funding for providers that have already received funds from the initial distribution of $30 billion. Unlike the first round of funds, which came automatically, providers were required to apply for these additional funds and submit the required supporting documentation, using the online portal provided by HHS. Providers were required to attest to and agree to specific terms and conditions for the use of such funds. HHS expressed a goal of allocating the whole $50 billion proportionally across all providers based on those providers’ proportional share of 2018 net Medicare fee-for-service revenue, so that some providers will not be eligible for additional funds. On May 22, 2020, HHS announced that it had begun distributing $4.9 billion in additional relief funds to SNFs to offset revenue losses and assist nursing homes with additional costs related to responding to the COVID-19 public health emergency and the shipments of personal protective equipment provided to nursing homes by the Federal Emergency Management Agency. On June 9, 2020, HHS announced that it expected to distribute approximately $15 billion to eligible providers that participate in state Medicaid and Children’s Health Insurance Program (“CHIP”) programs and have not received a payment from the Provider Relief Fund General Allocation. On July 22, 2020, President Trump announced that HHS would devote $5 billion in Provider Relief Funds to Medicare-certified long-term care facilities and state veterans’ homes to build nursing home skills and enhance nursing homes’ response to COVID-19, including enhanced infection control. Nursing homes were required to t participate in the Nursing Home COVID-19 training to qualify for this funding. On August 27, 2020, HHS announced that it had distributed almost $2.5 billion to nursing homes to support increased testing, staffing, and personal protective equipment needs. On September 3, 2020, HHS announced a $2 billion performance-based incentive payment distribution to nursing homes and SNFs. Finally, on October 1, 2020, the Trump Administration announced $20 billion in additional funding for several types of providers, including those who previously received, rejected, or accepted a general distribution provider relief fund payment. The application deadline for these Phase 3 funds was November 6, 2020.
On December 27, 2020, President Trump signed the Consolidated Appropriations Act, 2021 (H.R. 133). The $1.4 trillion omnibus appropriations legislation funds the government through September 30, 2021 and was attached to a $900 billion COVID-19 relief package. Of the $900 billion in COVID-19 relief, $73 billion was allocated to HHS. Notably, the bill adds an additional $3 billion to the Provider Relief Fund, includes language specific to reporting requirements, and allows providers to use any reasonable method to calculate lost revenue, including the difference between such provider’s budgeted and actual revenue budget if such budget had been established and approved prior to March 27, 2020, to demonstrate entitlement for these funds. This change reverts to HHS’ previous guidance from June 2020 on how to calculate lost revenues. The Consolidated Appropriations Act, 2021, also extended the CARES Act’s sequestration suspension to March 31, 2021. On January 15, 2021, HHS announced that it would be amending the reporting timeline for Provider Relief Funds and indicated that it was working to update the Provider Relief Fund requirements to be consistent with the passage of the Consolidated Appropriations Act, 2021.
On April 14, 2021, President Biden signed an Act to Prevent Across-the-Board Direct Spending Cuts, and for Other Purposes (H.R. 1868), which extended the sequestration suspension period to December 31, 2021. On June 11, 2021, HHS issued revised reporting requirements for recipients of Provider Relief Fund payments. The announcement included expanding the amount of time providers would have to report information, aimed to reduce burdens on smaller providers, and extended key deadlines for expending Provider Relief Fund payments for recipients who received payments after June 30, 2020. The revised reporting requirements are applicable to providers who received one or more payments exceeding, in the aggregate, $10,000 during a single Payment Received Period from the PRF General Distributions, Targeted Distributions, and/or Skilled Nursing Facility and Nursing Home Infection Control Distributions. On July 1, 2021, HHS, through the Health Resources and Services Administration (“HRSA”), notified recipients of Provider Relief Fund payments by e-mail that the Provider Relief Fund Reporting Portal was open for recipients who were required to report on the use of funds in Reporting Period 1, as described by HHS’s June 11, 2021 update to the reporting requirements. On September 10, 2021, HHS announced a final 60-day grace period of the September 30, 2021 reporting deadline for Provider Relief Funds exceeding $10,000 in aggregate payments received from April 10, 2020 to June 30, 2020. Although the September 30, 2021 reporting deadline remained in place, HHS has explained that recoupment or other enforcement actions will not be initiated during the 60-day grace period, which began on October 1, 2021 and will end on November 30, 2021.
On September 10, 2021, the Biden Administration announced that HHS would be making available $25.5 billion in new funding for health care providers affected by the COVID-19 pandemic, including $8.5 billion in American Rescue Plan (“ARP”) resources for providers who serve rural Medicaid, CHIP, or Medicare patients, and an additional $17 billion for Phase 4 Provider Relief Funds for a broad range of providers who can document revenue loss and expenses associated with the pandemic, including assisted living facilities that were state-licensed/certified on or before December 31, 2020. Approximately 25% of the Phase 4 allocation will be put towards bonus payments based on the amount and type of services provided to Medicaid, CHIP, and Medicare beneficiaries from January 1, 2019 through September 30, 2020. The deadline for submitting applications for Phase 4 funds is October 26, 2021.
On July 18, 2019, CMS published a final rule that eliminated the prohibition on pre-dispute binding arbitration agreements between long-term care facilities and their residents. The rule also strengthened the transparency of arbitration agreements and makes other changes to arbitration requirements for long-term care facilities. There can be no assurance that these rules or future regulations modifying Medicare skilled nursing facility payment rates or other requirements for Medicare and/or Medicaid participation will not have an adverse effect on the financial condition of our borrowers and lessees which could, in turn, adversely impact the timing or level of their payments to us.
Congress periodically considers legislation revising Medicare and Medicaid policies, including legislation that could have the impact of reducing Medicare reimbursement for SNFs and other Medicare providers, limiting state Medicaid funding allotments, encouraging home and community-based long-term care services as an alternative to institutional settings, or otherwise reforming payment policy for post-acute care services. Congress continues to consider further legislative action in response to the COVID-19 pandemic. There can be no assurances that enacted or future legislation will not have an adverse impact on the financial condition of our lessees and borrowers, which subsequently could materially adversely impact our company.
Additional reforms affecting the payment for and availability of health care services have been proposed at the federal and state level and adopted by certain states. Increasingly, state Medicaid programs are providing coverage through managed care programs under contracts with private health plans, which is intended to decrease state Medicaid costs. State Medicaid budgets may experience shortfalls due to increased costs in addressing the COVID-19 pandemic. Congress and state legislatures can be expected to continue to review and assess alternative health care delivery systems and payment methodologies. Changes in the law, new interpretations of existing laws, or changes in payment methodologies may have a dramatic effect on the definition of permissible or impermissible activities, the relative costs associated with doing business and the amount of reimbursement by the government and other third-party payors.
Key Performance Indicators, Trends and Uncertainties
We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results in making operating decisions and for budget planning purposes.
Concentration Risk. We evaluate by gross investment our concentration risk in terms of asset mix, real estate investment mix, operator mix and geographic mix. Concentration risk is valuable to understand what portion of our real estate investments could be at risk if certain sectors were to experience downturns. Asset mix measures the portion of our investments that are real property or mortgage loans. The National Association of Real Estate Investment Trusts (“NAREIT”), an organization representing U.S. REITs and publicly traded real estate companies, classifies a company with 50% or more of assets directly or indirectly in the equity ownership of real estate as an equity REIT. Investment mix measures the portion of our investments that relate to our various property classifications. Operator mix measures the portion of our investments that relate to our top five operators. Geographic mix measures the portion of our real estate investment that relate to our top five states.
The following table reflects our recent historical trends of concentration risk (gross investment, in thousands):
| Asset mix: | | 9/30/21 | | 6/30/21 | | 3/31/21 | | 12/31/20 | | 9/30/20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Real property | | $1,407,098 | | $1,412,329 | | $1,449,062 | | $1,452,001 | | $1,448,764 | |
| Loans receivable | | 261,437 | | 259,641 | | 259,874 | | 259,843 | | 260,267 | |
| Real estate investment mix: | | | | | | | | | | | |
| Assisted living communities | | $843,015 | | $840,502 | | $877,233 | | $880,172 | | $880,307 | |
| Skilled nursing centers | | 812,380 | | 820,108 | | 820,343 | | 820,312 | | 817,364 | |
| Other (1) | | 13,140 | | 11,360 | | 11,360 | | 11,360 | | 11,360 | |
| Operator mix: | | | | | | | | | | | |
| Prestige Healthcare (1) | | $272,789 | | $272,773 | | $273,007 | | $272,976 | | $273,399 | |
| Senior Care Centers/ Abri Health Services | | 138,315 | | 138,109 | | 138,109 | | 138,109 | | 138,109 | |
| Anthem Memory Care | | 136,483 | | 136,483 | | 136,483 | | 136,483 | | 136,483 | |
| Carespring Health Care Management | | 102,520 | | 102,520 | | 102,520 | | 102,520 | | 102,520 | |
| Brookdale Senior Living | | 102,261 | | 101,240 | | 101,012 | | 100,613 | | 98,921 | |
| Remaining operators | | 916,167 | | 920,845 | | 957,805 | | 961,143 | | 959,599 | |
| Geographic mix: | | | | | | | | | | | |
| Michigan | | $282,022 | | $281,762 | | $281,995 | | $281,963 | | $282,103 | |
| Texas | | 274,204 | | 273,588 | | 273,468 | | 273,287 | | 273,075 | |
| Wisconsin | | 114,288 | | 114,250 | | 149,403 | | 149,403 | | 149,403 | |
| California | | 105,997 | | 105,892 | | 105,352 | | 105,163 | | 104,924 | |
| Colorado | | 104,445 | | 104,347 | | 104,307 | | 104,090 | | 106,879 | |
| Remaining states | | 787,579 | | 792,131 | | 794,411 | | 797,938 | | 792,647 | |
(1) Includes three parcels of land located adjacent to properties securing the Prestige Healthcare mortgage loan and are managed by Prestige.
Credit Strength. We measure our credit strength both in terms of leverage ratios and coverage ratios. Our leverage ratios include debt to gross asset value and debt to market capitalization. The leverage ratios indicate how much of our Consolidated Balance Sheets capitalization is related to long-term obligations. Our coverage ratios include interest coverage ratio and fixed charge coverage ratio. The coverage ratios indicate our ability to service interest and fixed charges (interest). The coverage ratios are based on earnings before interest, taxes, depreciation and amortization for real estate (“EBITDAre”) as defined by NAREIT. EBITDAre is calculated as net income available to common stockholders (computed in accordance with GAAP) excluding (i) interest expense, (ii) income tax expense, (iii) real estate depreciation and amortization, (iv) impairment write-downs of depreciable real estate, (v) gains or losses on the sale of depreciable real estate, and (vi) adjustments for unconsolidated partnerships and joint ventures. Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. The following table reflects the recent historical trends for our credit strength measures:
Balance Sheet Metrics
| | | Year to Date 9/30/21 | Quarter Ended 9/30/21 | | 6/30/21 | | 3/31/21 | | 12/31/20 | | 9/30/20 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt to gross asset value | | 36.3% | 36.3% | (1) | 34.8% | (3) | 36.3% | (1) | 35.8% | (3) | 36.5% |
| Debt to market capitalization ratio | | 34.7% | 34.7% | (2) | 29.0% | (4) | 28.7% | (6) | 29.8% | (7) | 32.7% |
| Interest coverage ratio (9) | | 4.4 x | 4.3 x | | 4.3 x | (5) | 4.6 x | (5) | 5.3 x | (8) | 4.8 x |
| Fixed charge coverage ratio (9) | | 4.4 x | 4.3 x | | 4.3 x | (5) | 4.6 x | (5) | 5.3 x | (8) | 4.8 x |
(1) Increased due to increase in outstanding debt partially offset by increase in gross asset value.
(2) Increased due to decrease in market capitalization and increase in outstanding debt.
(3) Decreased due to decrease in outstanding debt partially offset by decrease in gross asset value.
(4) Increased due to decrease in market capitalization, partially offset by decrease in outstanding debt.
(5) Decreased due to decrease in rental income partially offset by decrease in interest expense.
(6) Decreased due to increase in market capitalization partially offset by increase in outstanding debt.
(7) Decreased due to decrease in outstanding debt and increase in market capitalization.
(8) Increased due to decrease in interest expense and increase in rental income.
(9) In calculating our interest coverage and fixed charge coverage ratios above, we use EBITDAre, which is a financial measure not derived in accordance with GAAP (non-GAAP financial measure). EBITDAre is not an alternative to net income, operating income or cash flows from operating activities as calculated and presented in accordance with GAAP. You should not rely on EBITDAre as a substitute for any such GAAP financial measures or consider it in isolation, for the purpose of analyzing our financial performance, financial position or cash flows. Net income is the most directly comparable GAAP measure to EBITDAre.
| | | Year to Date 9/30/21 | | Quarter Ended 9/30/21 | | 6/30/21 | | 3/31/21 | | 12/31/20 | | 9/30/20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | | $43,294 | | $11,114 | | $18,330 | | $13,850 | | $17,665 | | $12,338 | |
| Less/Add: (Gain)/ loss on sale | | (7,392) | | (2,702) | | (5,463) | | 773 | | (44) | | (30) | |
| Add: Loss on unconsolidated joint ventures | | — | | — | | — | | — | | 138 | | — | |
| Add: Impairment loss | | — | | — | | — | | — | | 3,036 | | 941 | |
| Add: Interest expense | | 20,442 | | 6,610 | | 6,860 | | 6,972 | | 7,088 | | 7,361 | |
| Add: Depreciation and amortization | | 28,847 | | 9,462 | | 9,508 | | 9,877 | | 9,839 | | 9,766 | |
| EBITDAre | | $85,191 | | $24,484 | | $29,235 | | $31,472 | | $37,722 | | $30,376 | |
| Add (less): Non-recurring one-time items | | 4,653 | | 3,895 | (1) | — | | 758 | (2) | — | | 5,099 | (3) |
| Adjusted EBITDAre | | $89,844 | | $28,379 | | $29,235 | | $32,230 | | $37,722 | | $35,475 | |
| | | | | | | | | | | | | | |
| Interest expense | | $20,442 | | $6,610 | | $6,860 | | $6,972 | | $7,088 | | $7,361 | |
| Add: Capitalized interest | | — | | — | | — | | — | | — | | 77 | |
| Interest incurred | | $20,442 | | $6,610 | | $6,860 | | $6,972 | | $7,088 | | $7,438 | |
| | | | | | | | | | | | | | |
| Interest coverage ratio | | 4.4 | x | 4.3 | x | 4.3 | x | 4.6 | x | 5.3 | x | 4.8 | x |
| | | | | | | | | | | | | | |
| Interest incurred | | $20,442 | | $6,610 | | $6,860 | | $6,972 | | $7,088 | | $7,438 | |
| Total fixed charges | | $20,442 | | $6,610 | | $6,860 | | $6,972 | | $7,088 | | $7,438 | |
| | | | | | | | | | | | | | |
| Fixed charge coverage ratio | | 4.4 | x | 4.3 | x | 4.3 | x | 4.6 | x | 5.3 | x | 4.8 | x |
(1) Represents the Senior Care and Abri Health settlement and related fees.
(2) Represents the write-off of straight-line rent related to an operator.
(3) Represents the write-off of straight-line rent receivable related to Genesis and another operator offset by the gain from insurance proceeds related to a previously sold property.
We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved, and actual results may differ materially from our expectations. This may be a result of various factors, including, but not limited to
- The status of the economy;
- The status of capital markets, including prevailing interest rates;
- Compliance with and changes to regulations and payment policies within the health care industry;
- Changes in financing terms;
- Competition within the health care and seniors housing industries; and
- Changes in federal, state and local legislation.
Additionally, as described in the Executive Overview above, COVID-19 is adversely affecting and is expected to continue to adversely affect our business, results of operations, cash flows and financial condition. Depending on the future developments regarding COVID-19, the duration, spread and severity of the outbreak, historical trends reflected in our balance sheet metrics may not be achieved in the future.
Management regularly monitors the economic and other factors listed above. We develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends.
Operating Results (unaudited, in thousands)
| Revenues: | | Three Months Ended September 30, 2021 | | 2020 | | Difference | |
|---|---|---|---|---|---|---|---|
| Rental income | | $29,320 | | $30,010 | | $(690) | (1) |
| Interest income from mortgage loans | | 7,924 | | 7,890 | | 34 | |
| Interest and other income | | 228 | | 273 | | (45) | |
| Total revenues | | 37,472 | | 38,173 | | (701) | |
| | | | | | | | |
| Expenses: | | | | | | | |
| Interest expense | | 6,610 | | 7,361 | | 751 | (2) |
| Depreciation and amortization | | 9,462 | | 9,766 | | 304 | |
| Impairment charges | | — | | 941 | (3) | 941 | |
| Provision (recovery) for credit losses | | 68 | | (2) | | (70) | |
| Transaction costs | | 4,046 | | 63 | | (3,983) | (4) |
| Property tax expense | | 3,932 | | 3,351 | | (581) | (5) |
| General and administrative expenses | | 5,318 | | 4,814 | | (504) | (6) |
| Total expenses | | 29,436 | | 26,294 | | (3,142) | |
| | | | | | | | |
| Other operating income: | | | | | | | |
| Gain on sale of real estate, net | | 2,702 | (7) | 30 | (8) | 2,672 | |
| Operating income | | 10,738 | | 11,909 | | (1,171) | |
| Gain from property insurance proceeds | | — | | 373 | (9) | (373) | |
| Loss on unconsolidated joint ventures | | — | | — | | — | |
| Income from unconsolidated joint ventures | | 376 | | 56 | | 320 | (10) |
| Net income | | 11,114 | | 12,338 | | (1,224) | |
| Income allocated to non-controlling interests | | (92) | | (121) | | 29 | |
| Net income attributable to LTC Properties, Inc. | | 11,022 | | 12,217 | | (1,195) | |
| Income allocated to participating securities | | (113) | | (103) | | (10) | |
| Net income available to common stockholders | | $10,909 | | $12,114 | | $(1,205) | |
(1) Decreased primarily due to unpaid rent from Senior Care and Abri Health, Senior Lifestyle non-payment of lease obligations, abated and deferred rent and reduced income from a sold SNF in Washington partially offset by a $5,472 write-off of straight-line rent receivable balances related to two operators during the third quarter of 2020, increased rent from re-leasing 18 properties previously leased to Senior Lifestyle, completed development projects, an increase in property tax revenue and contractual rent increases.
(2) Decreased primarily due to scheduled principal paydowns on our senior unsecured notes and lower rates and a lower average outstanding balance under our unsecured revolving line of credit.
(3) Represents an impairment loss related to a closed ALF in Florida which was sold during the first quarter of 2021.
(4) Increased due to the Senior Care and Abri Health settlement and related fees.
(5) Increased primarily due to higher property tax expense related to Senior Lifestyle’s default of their contractual obligations to pay real estate taxes.
(6) Increased primarily due to higher incentive compensation projected in 2021 than in prior year and an increase in non-cash restricted stock and performance-based stock vesting expense.
(7) Represents the net gain on sale of $2,562 related to a SNF in Washington and (8) below.
(8) Represents recognition of additional gain due to quarterly reassessment of prior years’ sale holdbacks.
(9) Represents gain on insurance proceeds related to roof damage at a 114-bed SNF in Texas sold during the first quarter of 2020.
(10) Increased due to preferred equity investments in two unconsolidated joint ventures.
| Revenues: | | Nine Months Ended September 30, 2021 | | 2020 | | Difference | |
|---|---|---|---|---|---|---|---|
| Rental income | | $91,097 | | $88,320 | | $2,777 | (1) |
| Interest income from mortgage loans | | 23,779 | | 23,487 | | 292 | (2) |
| Interest and other income | | 1,005 | | 1,257 | | (252) | (3) |
| Total revenues | | 115,881 | | 113,064 | | 2,817 | |
| | | | | | | | |
| Expenses: | | | | | | | |
| Interest expense | | 20,442 | | 22,617 | | 2,175 | (4) |
| Depreciation and amortization | | 28,847 | | 29,232 | | 385 | |
| Impairment charges | | — | | 941 | (5) | 941 | |
| Provision (recovery) for credit losses | | 59 | | (1) | | (60) | |
| Transaction costs | | 4,271 | | 197 | | (4,074) | (6) |
| Property tax expense | | 11,713 | | 11,685 | | (28) | |
| General and administrative expenses | | 15,688 | | 14,494 | | (1,194) | (7) |
| Total expenses | | 81,020 | | 79,165 | | (1,855) | |
| | | | | | | | |
| Other operating income: | | | | | | | |
| Gain on sale of real estate, net | | 7,392 | (8) | 44,073 | (9) | (36,681) | |
| Operating income | | 42,253 | | 77,972 | | (35,719) | |
| Gain from property insurance proceeds | | — | | 373 | (10) | (373) | |
| Loss on unconsolidated joint ventures | | — | | (620) | (11) | 620 | |
| Income from unconsolidated joint ventures | | 1,041 | | 287 | | 754 | (12) |
| Net income | | 43,294 | | 78,012 | | (34,718) | |
| Income allocated to non-controlling interests | | (271) | | (292) | | 21 | |
| Net income attributable to LTC Properties, Inc. | | 43,023 | | 77,720 | | (34,697) | |
| Income allocated to participating securities | | (346) | | (339) | | (7) | |
| Net income available to common stockholders | | $42,677 | | $77,381 | | $(34,704) | |
(1) Increased primarily due to a $23,214 write-off of straight-line rent receivable and lease incentive balances related to three operators during 2020, increased rent from re-leasing 18 properties previously leased to Senior Lifestyle, completed development projects and contractual rent increases partially offset due to non-payment of lease obligations from Senior Lifestyle, unpaid lease obligations from Senior Care and Abri Health, abated and deferred rent, net of repayment, a $758 straight-line rent receivable write-off during 2021, a decrease in property tax revenue, reduced rent from sold properties and 50% reduction of 2021 rent escalations.
(2) Increased due to mortgage originations and capital improvement funding offset by scheduled principal paydowns and 50% reduction of 2021 interest escalation.
(3) Decreased primarily due to the payoff of a mezzanine loan offset by additional notes receivable funding.
(4) Decreased primarily due to scheduled principal payments on our senior unsecured notes and lower interest rates and a lower average outstanding balance under our unsecured revolving line of credit.
(5) Represents an impairment loss related to a closed ALF in Florida which was sold during the first quarter of 2021.
(6) Increased primarily due to the Senior Care and Abri Health settlement and related fees.
(7) Increased primarily due to higher incentive compensation projected in 2021 than in prior year and an increase in non-cash restricted stock and performance-based stock vesting expense.
(8) Represents the net gain on sale of $2,562 related to a SNF in Washington, $5,594 related to three ALFs in Wisconsin and $292 of quarterly reassessment of the prior years’ sale holdbacks partially offset by the net loss on sale of $198 related to a closed ALF in Nebraska and the net loss on sale of $858 related to a closed property in Florida.
(9) Represents net gain on sale of 21 SNFs within the Preferred Care portfolio and recognition of additional gain due to quarterly reassessment of prior years’ sale holdbacks.
(10) Represents gain on insurance proceeds related to roof damage at a 114-bed SNF in Texas sold during the first quarter of 2020.
(11) Relates to the sale of properties comprising a joint venture in which we had a preferred equity investment.
(12) Increased due to preferred equity investments in two unconsolidated joint ventures.
Funds From Operations Available to Common Stockholders
Funds from Operations (“FFO”) attributable to common stockholders, basic FFO attributable to common stockholders per share and diluted FFO attributable to common stockholders per share are supplemental measures of a REIT’s financial performance that are not defined by GAAP. Real estate values historically rise and fall with market conditions, but cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. We believe that by excluding the effect of historical cost depreciation, which may be of limited relevance in evaluating current performance, FFO facilitates comparisons of operating performance between periods.
We use FFO as a supplemental performance measurement of our cash flow generated by operations. FFO does not represent cash generated from operating activities in accordance with GAAP, and is not necessarily indicative of cash available to fund cash needs and should not be considered an alternative to net income available to common stockholders.
We calculate and report FFO in accordance with the definition and interpretive guidelines issued by NAREIT. FFO, as defined by NAREIT, means net income available to common stockholders (computed in accordance with GAAP) excluding gains or losses on the sale of real estate and impairment write-downs of depreciable real estate plus real estate depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures. Our calculation of FFO may not be comparable to FFO reported by other REITs that do not define the term in accordance with the current NAREIT definition or that have a different interpretation of the current NAREIT definition from us; therefore, caution should be exercised when comparing our FFO to that of other REITs.
The following table reconciles GAAP net income available to common stockholders to NAREIT FFO available to common stockholders (unaudited, amounts in thousands, except per share amounts):
| | | Three Months Ended September 30, 2021 | | 2020 | | Nine Months Ended September 30, 2021 | | 2020 | |
|---|---|---|---|---|---|---|---|---|---|
| GAAP net income available to common stockholders | | $10,909 | | $12,114 | | $42,677 | | $77,381 | |
| Add: Depreciation and amortization | | 9,462 | | 9,766 | | 28,847 | | 29,232 | |
| Add: Impairment loss from investments | | — | | 941 | | — | | 941 | |
| Add: Loss on unconsolidated joint ventures | | — | | — | | — | | 620 | |
| Less: Gain on sale of real estate, net | | (2,702) | | (30) | | (7,392) | | (44,073) | |
| NAREIT FFO attributable to common stockholders | | $17,669 | | $22,791 | | $64,132 | | $64,101 | |
| NAREIT FFO attributable to common stockholders per share: | | | | | | | | | |
| Basic | | $0.45 | | $0.58 | | $1.64 | | $1.63 | |
| Diluted | | $0.45 | | $0.58 | (1) | $1.64 | | $1.63 | |
| Weighted average shares used to calculate NAREIT FFO per share: | | | | | | | | | |
| Basic | | 39,177 | | 39,061 | | 39,149 | | 39,218 | |
| Diluted | | 39,177 | | 39,293 | (2) | 39,149 | | 39,269 | (3) |
(1) Includes the effect of participating securities.
(2) Includes the effect of performance-based stock units and participating securities.
(3) Includes the effect of performance-based stock units.
Liquidity and Capital Resources
Sources and Uses of Cash
As of September 30, 2021, we had a total of $45.5 million of cash and cash equivalents, $465.6 million available under our unsecured revolving line of credit and the potential ability to access the capital markets through the issuance of $200.0 million of common stock under our Equity Distribution Agreements. Furthermore, we have the ability to access the capital markets through the issuance of debt and/ or equity securities under an automatic shelf registration statement.
We believe that our current cash balance, cash flow from operations available for distribution or reinvestment, our borrowing capacity and our potential ability to access the capital markets are sufficient to provide for payment of our current operating costs, meet debt obligations and pay common dividends at least sufficient to maintain our REIT status and repay borrowings at, or prior to, their maturity. The timing, source and amount of cash flows used in financing and investing activities are sensitive to the capital markets environment, especially to changes in interest rates. In addition, as described in “Item 1A. Risk Factors”, COVID-19 has adversely affected and is expected to continue to adversely affect our operators’ business, results of operations, cash flows and financial condition which could, in turn, adversely affect our financial position.
The operating results of the facilities will be impacted by various factors over which the operators/owners may have no control. Those factors include, without limitation, the health of the economy, changes in supply of or demand for competing seniors housing and health care facilities, ability to control rising operating costs, the potential for significant reforms in the health care industry, and the impact of COVID-19. In addition, our future growth in net income and cash flow may be adversely impacted by various proposals for changes in the governmental regulations and financing of the health care industry, and the impact of COVID-19. We cannot presently predict what impact these proposals may have, if any. We believe that an adequate provision has been made for the possibility of loans proving uncollectible but we will continually evaluate the financial status of the operations of the seniors housing and health care properties. In addition, we will monitor our borrowers and the underlying collateral for mortgage loans and will make future revisions to the provision, if considered necessary.
Depending on the duration, spread and severity of the outbreak, our borrowing capacity, compliance with financial covenants, ability to access the capital markets, and the payment of dividends may be negatively impacted. We continuously evaluate the availability of cost-effective capital and believe we have sufficient liquidity for corporate expenses and additional capital investments in 2021 and 2022.
Our investments, principally our investments in owned properties and mortgage loans, are subject to the possibility of loss of their carrying values as a result of changes in market prices, interest rates and inflationary expectations. The effects on interest rates may affect our costs of financing our operations and the fair market value of our financial assets. Generally, our leases have agreed upon annual increases and our loans have predetermined increases in interest rates. Inasmuch as we may initially fund some of our investments with variable interest rate debt, we would be at risk of net interest margin deterioration if medium and long-term rates were to increase.
Our primary sources of cash include rent and interest receipts, borrowings under our unsecured credit facility, public and private issuances of debt and equity securities, proceeds from investment dispositions and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including acquisitions, capital expenditures and construction advances), loan advances and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows as summarized below (in thousands):
| Cash provided by (used in): | | Nine Months Ended September 30, 2021 | | 2020 | | Change $ | |
|---|---|---|---|---|---|---|---|
| Operating activities | | $69,581 | | $85,629 | | $(16,048) | |
| Investing activities | | 27,757 | | 51,982 | | (24,225) | |
| Financing activities | | (59,651) | | (119,044) | | 59,393 | |
| Increase in cash, cash equivalents and restricted cash | | 37,687 | | 18,567 | | 19,120 | |
| Cash, cash equivalents and restricted cash, beginning of period | | 7,772 | | 4,244 | | 3,528 | |
| Cash, cash equivalents and restricted cash, end of period | | $45,459 | | $22,811 | | $22,648 | |
Debt Obligations
Bank Borrowings. We have an Unsecured Credit Agreement that provides for a revolving line of credit up to $600.0 million in aggregate commitment of the lenders and the opportunity to increase the commitment size of the credit agreement up to a total of $1.0 billion. The Unsecured Credit Agreement matures on June 27, 2022 and provides for a one-year extension option at our discretion, subject to customary conditions. Based on our leverage at September 30, 2021, the facility provides for interest annually at LIBOR plus 115 basis points and a facility fee of 20 basis points. At September 30, 2021, we were in compliance with all covenants.
Senior Unsecured Notes. We have senior unsecured notes held by institutional investors with interest rates ranging from 3.85% to 5.03%. The senior unsecured notes mature between 2021 and 2032.
The debt obligations by component as of September 30, 2021 are as follows (dollar amounts in thousands):
| Debt Obligations | | Applicable Interest Rate (1) | | Outstanding Balance | | Available for Borrowing |
|---|---|---|---|---|---|---|
| Bank borrowings | | 1.23% | | $134,400 | | $465,600 |
| Senior unsecured notes, net of debt issue costs | | 4.34% | | 527,429 | | — |
| Total | | 3.71% | | $661,829 | | $465,600 |
(1) Represents weighted average of interest rate as of September 30, 2021.
Our debt borrowings and repayments during the nine months ended September 30, 2021 are as follows (in thousands):
| Debt Obligations | | Borrowings | | Repayments | |
|---|---|---|---|---|---|
| Bank borrowings | | $92,500 | | $(48,000) | |
| Senior unsecured notes | | — | | (32,160) | |
| Total | | $92,500 | | $(80,160) | |
Equity
At September 30, 2021, we had 39,374,044 shares of common stock outstanding, equity on our balance sheet totaled $752.9 million and our equity securities had a market value of $1.2 billion. During the nine months ended September 30, 2021, we declared and paid $68.1 million of cash dividends.
Subsequent to September 30, 2021, we declared a monthly cash dividend of $0.19 per share on our common stock for the months of October, November and December 2021, payable on October 29,
November 30, and December 31, 2021, respectively, to stockholders of record on October 21, November 19, and December 23, 2021, respectively.
At-The-Market Program. We have separate equity distribution agreements (collectively, “Equity Distribution Agreements”) to offer and sell, from time to time, up to $200.0 in aggregate offering price of shares of our common stock. As of September 30, 2021, no shares had been issued under the Equity Distribution Agreements. Accordingly, at September 30,2021, we had $200.0 available under the Equity Distribution Agreements.
Available Shelf Registrations. We have an automatic shelf registration statement on file with the SEC and currently have the ability to file additional automatic shelf registration statements to provide us with capacity to publicly offer an indeterminate amount of common stock, preferred stock, warrants, debt, depositary shares, or units. We may from time to time raise capital under our automatic registration statement in amounts, at prices, and on terms to be announced when and if the securities are offered. The specifics of any future offerings, along with the use of proceeds of any securities offered, will be described in detail in a prospectus supplement, or other offering materials, at the time of the offering. Our shelf registration statement expires on February 28, 2022.
Stock-Based Compensation. During the second quarter of 2021, we adopted and our shareholders approved the 2021 Equity Participation Plan (“the 2021 Plan”) which replaces the 2015 Equity Participation Plan (“the 2015 Plan”). Under the 2021 Plan, 1,900,000 shares of common stock have been authorized and reserved for awards, less one share for every one share that was subject to an award granted under the 2015 Plan after December 31, 2020 and prior to adoption. In addition, any shares that are not issued under outstanding awards under the 2015 Plan because the shares were forfeited or cancelled after December 31, 2020 will be added to and again be available for awards under the 2021 Plan. Under the 2021 Plan, the shares were authorized and reserved for awards to officers, employees, non-employee directors and consultants. The terms of the awards granted under the 2021 Plan and the 2015 Plan are set by our compensation committee at its discretion.
During the nine months ended September 30, 2021, we granted restricted stock and performance-based stock units as follows:
| No. of Shares | | Price per Share | | Vesting Period | |
|---|---|---|---|---|---|
| 95,293 | | $42.27 | | ratably over 3 years | |
| 71,892 | | $42.27 | | TSR targets (1) | |
| 12,055 | | $39.40 | | May 26, 2022 | |
| 3,000 | | $43.14 | | April 1, 2022 | |
| 182,240 | | | | | |
(1) Vesting is based on achieving certain total shareholder return (“TSR”) targets in 4 years with an acceleration opportunity in 3 years.
Critical Accounting Policies
Our consolidated financial statements included in Part I, Item 1 of this Quarterly Report on Form 10-Q are prepared in conformity with U.S. generally accepted accounting principles for interim financial information set forth in the Accounting Standards Codification as published by the Financial Accounting Standards Board, which require us to make estimates and assumptions regarding future events that affect the amounts reported in our financial statements and accompanying footnotes. We base these estimates on our experience and assumptions regarding future events we believe to be reasonable under the circumstances. Actual results could differ from those estimates and such differences may be material to the consolidated financial statements. We have described our most critical accounting policies in our
Annual Report on Form 10-K for the year ended December 31, 2020. There have been no material changes to our critical accounting policies or estimates since December 31, 2020.
Market risk
As filed, 228 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There were no material changes in our market risk during the nine months ended September 30, 2021. For additional information, refer to Item 7A as presented in our Annual Report on Form 10-K for the year ended December 31, 2020.
Controls and procedures
As filed, 799 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities and Exchange Act of 1934, as amended). As of the end of the period covered by this report based on such evaluation our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, our disclosure controls and procedures were effective.
There has been no change in our internal control over financial reporting during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
PART II
OTHER INFORMATION
Risk factors
As filed, 1,366 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The additional risk factor below should be read in conjunction with the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020.
Inflation Could Adversely Impact Our Tenants And Our Results Of Operations.
Inflation, both real or anticipated as well as any resulting governmental policies, could adversely affect the economy and the costs of labor, goods and services to our tenants. Our long-term leases and loans typically contain provisions, such as rent escalators, designed to mitigate the adverse impact of inflation. However, in 2021 we provided deferred and abated rent to certain operators and reduced 2021 rent and interest escalations by 50% to support eligible operators during the continuing COVID-19 crisis. Because tenants are typically required to pay all property operating expenses, increases in property-level expenses at our leased properties generally do not directly affect us. Increased operating costs could have an adverse impact on our tenants if increases in their operating expenses exceed increases in their revenue, which may adversely affect our tenants’ ability to pay rent owed to us. An increase in our tenants’ expenses and a failure of their revenues to increase at least with inflation could adversely impact our tenants’ and our financial condition and our results of operations.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2021-07-01 to 2021-09-30 | $37.5m | us-gaap:Revenues |
| Revenue | 9 months2021-01-01 to 2021-09-30 | $115.9m | us-gaap:Revenues |
| Operating income | 3 months2021-07-01 to 2021-09-30 | $10.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2021-01-01 to 2021-09-30 | $42.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $6.6m | us-gaap:InterestExpense |
| Interest expense | 9 months2021-01-01 to 2021-09-30 | $20.4m | us-gaap:InterestExpense |
| Income tax | 9 months2021-01-01 to 2021-09-30 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2021-07-01 to 2021-09-30 | $11.0m | us-gaap:NetIncomeLoss |
| Net income | 9 months2021-01-01 to 2021-09-30 | $43.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2021-07-01 to 2021-09-30 | $0.28 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2021-01-01 to 2021-09-30 | $1.09 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2021-07-01 to 2021-09-30 | $0.28 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2021-01-01 to 2021-09-30 | $1.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2021-07-01 to 2021-09-30 | 39,177,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2021-01-01 to 2021-09-30 | 39,149,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2021-01-01 to 2021-09-30 | $69.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 9 months2021-01-01 to 2021-09-30 | $68.1m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2021-09-30 | $45.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2021-09-30 | $1.45bn | us-gaap:Assets |
| Total liabilities | At period end2021-09-30 | $700.2m | us-gaap:Liabilities |
| Long-term debt | At period end2021-09-30 | $661.8m | us-gaap:LongTermDebt |
| Shareholders' equity | At period end2021-09-30 | $744.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001558370-21-013726. Last ingested by Listed: Nov 5, 2026, 18:27 ET. Listed shows no prices and gives no investment advice.